The microbiome of aseptically collected human breast tissue in benign and malignant disease

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Hieken, Tina J ^a   Chen, Jun ^a   Hoskin, Tanya L ^a   Walther Antonio, Marina ^a   Johnson, Stephen ^a   Ramaker, Sheri ^a   Xiao, Jian ^a   Radisky, Derek C ^b   Knutson, Keith L ^c   Kalari, Krishna R ^a   Yao, Janet Z ^a   Baddour, Larry M ^a   Chia, Nicholas ^a,c   Degnim, Amy C ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; RIBOSOME DNA; RNA 16S;

ADULT; AGED; ASEPSIS; BACTERIUM; BREAST; BREAST DISEASE; BREAST TUMOR; CLASSIFICATION; DNA SEQUENCE; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PHYLOGENY; PROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASEPSIS; BACTERIA; BREAST; BREAST DISEASES; BREAST NEOPLASMS; DNA, BACTERIAL; DNA, RIBOSOMAL; FEMALE; HUMANS; MICROBIOTA; MIDDLE AGED; PHYLOGENY; PROSPECTIVE STUDIES; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84981350540     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30751     Document Type: Article

References (38)

1. Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin. 61, 69-90 (2011).
2. Rockhill, B., Spiegelman, D., Byrne, C., Hunter, D. J. & Colditz, G. A. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J. Natl. Cancer Inst. 93, 358-466 (2001).
3. Pankratz, V. S. et al. Model for individualized prediction of breast cancer risk after a benign breast biopsy. J. Clin. Oncol. 33, 923-929 (2015).
4. Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299-306 (2012).
5. Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292-298 (2012).
6. Kostic, A. D., Chun, E., Meyerson, M. & Garrett, W. S. Microbes and inflammation in colorectal cancer. Cancer Immunol. Res. 1, 150-157 (2013).
7. Burns, M. B., Lynch, J., Starr, T. K., Knights, D. & Blekhman, R. Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment. Genome Medicine 7, 55 (2015).
8. Wotherspoon, A. C. et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342, 575-577 (1993).
9. Fukase, K. et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372, 392-407 (2008).
10. Degnim, A. C. et al. Immune cell quantitation in normal breast tissue lobules with and without lobulitis. Breast Cancer Res. Treat. 144, 539-549 (2014).
11. Forman, D. et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302, 1302-1305 (1991).
12. Uemura, N. et al. Helicobacter pylori infection and the development of gastric cancer. N. Eng. J. Med. 345, 784-789 (2001).
13. Ahn, J. et al. Human gut microbiome and risk for colorectal cancer. J. Natl. Cancer Inst. 105, 1907-1911 (2013).
14. Schwabe, R. F. & Jobin, C. The microbiome and cancer. Nat. Rev. Cancer 13, 800-812 (2013).
15. Reddy, B. S. & Watanabe, K. Effect of intestinal microflora on 2,2-dimethyl-4-aminobiphenyl-induced carcinogenesis in F344 rats. J. Natl. Cancer Inst. 61, 1269-1271 (1978).
16. Hunt, K. M. et al. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLos One 6, e21313 (2011).
17. Cabrera-Rubio, R. et al. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am. J. Clin. Nutr. 96, 544-551 (2012).
18. Adlercreutz, H., Pulkkinen, M. O., Hamalainen, E. K. & Korpela, J. T. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones. J. Steroid Biochem. 20, 217-229 (1984).
19. Flores, R. et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J. Transl. Med. 10, 253 (2012).
20. Ransjo, U. O. A. A., Gylbert, L. & Jurelll, G. Bacteria in the female breast. Scand. J. Plast. Reconstr. Surg. 19, 87-89 (1985).
21. Thornton, J. W., Argenta, L. C., McClatchey, K. D. & Marks, M. W. Studies on the endogenous flora of the human breast. Ann. Plast. Surg. 20, 39-42 (1988).
22. Chen, J. et al. Associating microbiome composition with environmental covariates using generalized UniFrac distances. Bioinformatics 28, 2106-2113 (2012).
23. Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31, 814-821 (2013).
24. Xuan, C. et al. Microbial dysbiosis is associated with human breast cancer. PLos One 9, e83744 (2014).
25. Urbaniak, C. et al. Microbiota of human breast tissue. Appl. Environ. Microbiol. 80, 3007-3114 (2014).
26. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214 (2012).
27. Marchesi, J. R. et al. Towards the human colorectal cancer microbiome. PLos One 6, e20447 (2011).
28. Hoffman, R. M. Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey. Expert Opin. Biol. Ther. 15, 21-31 (2015).
29. Cavuoto, P. & Fenech, M. F. A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension. Cancer Treat. Rev. 38, 726-736 (2012).
30. Arroyo, R. et al. Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clin. Infect. Dis. 50, 1551-1558 (2010).
31. Fernandez, L. et al. Prevention of Infectious Mastitis by Oral Administration of Lactobacillus salivarius PS2 During Late Pregnancy. Clin. Infect. Dis. 62, 568-573 (2016).
32. Lakritz, J. R. et al. Gut bacteria require neutrophils to promote mammary tumorigenesis. Oncotarget 6, 9387-9396 (2015).
33. Seto, C. T., Jeraldo, P., Orenstein, R., Chia, N. & DiBaise, J. K. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome 2, 42 (2014).
34. Jeraldo, P. et al. IM-TORNADO: a tool for comparison of 16S reads from paired-end libraries. PLos One 9, e114804 (2014).
35. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-336 (2010).
36. Caporaso, J. G. et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. Isme J. 6, 1621-1624 (2012).
37. Zhao, N. et al. Testing in Microbiome-Profiling Studies with MiRKAT, the Microbiome Regression-Based Kernel Association Test. Am. J. Hum. Genet. 96, 797-807 (2015).
38. Breiman, L. Random forests. Mach. Learn. 45, 5-32 (2001).